Clinical Trials on Meningitis, Viral in Spain

Total 937 results

M. Carmen Cabellos Minguez
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital Universitario... and other collaborators

Terminated

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

Seizures | Pneumococcal Meningitis

Spain
Pfizer

Terminated

Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

Meningitis, Meningococcal

Spain
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Finland, Germany, Hungary, Spain
Novartis Vaccines
GlaxoSmithKline

Completed

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Meningococcal Meningitis | Meningoccocal Disease

Hungary, Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

Pneumococcal Meningitis

Spain
Novartis Vaccines

Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Meningococcal Disease | Meningococcal Meningitis

Spain, Italy, United Kingdom, Czech Republic
Novartis Vaccines

Completed

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Meningococcal Disease | Meningococcal Meningitis

Spain, Brazil, Hungary, Peru
Pfizer

Completed

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Meningitis, Meningococcal

Poland, Spain, Australia
Pfizer

Completed

NeisVac-C Single Prime Study in Infants

Neisseria Meningitidis

Poland, Spain
Novartis Vaccines
GlaxoSmithKline

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Meningococcal Disease | Meningococcal Meningitis

Belgium, Czechia, Germany, Italy, Spain, United Kingdom
Pfizer

Completed

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Meningitis, Meningococcal

United States, Australia, Spain, Chile, Finland, Denmark, Estonia, Czech Republic, Germany, Lithuania, Poland, Sweden
GlaxoSmithKline

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Meningitis, Meningococcal

Spain, Finland, Estonia, South Africa, Brazil, Mexico, Russian Federation, France, Turkey
GlaxoSmithKline

Completed

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
Asociacion para el Estudio de las Enfermedades...
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon...

Completed

Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome (Resistir)

Cytokine Release Syndrome | Disease, Viral | TLRs

Spain
Ministry of Health, Spain

Completed

High Flow Therapy vs Hypertonic Saline in Bronchiolitis

Acute Viral Bronchiolitis

Spain
Valme University Hospital
Boehringer Ingelheim

Unknown

Influence of Nevirapine on HCV Viral Load (HELICON)

HCV Infection. | HCV Viral Load.

Spain
Guadarrama Hospital
Fisiobronquial Clínicas

Completed

Safety of Airway Clearance in Non-hospitalized Infants With Acute Viral Bronchiolitis

Bronchiolitis

Spain
Catalysis SL
Atika Pharma S.L.

Recruiting

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Papilloma Viral Infection | CIN1 | LSIL, Low Grade Squamous Intraepithelial Lesion

Spain
GlaxoSmithKline

Completed

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Spain

Viral Conjunctivitis

Spain
Hospital Universitario Infanta Leonor

Completed

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid ((UMC))

HIV Infections | Drug Use | HCV Infection | HBV (Hepatitis B Virus) | Viral Hepatitis

Spain
GlaxoSmithKline

Completed

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain, Germany, Poland
Fundacion IMIM

Completed

ADHEPTA Study: Adherence Questionnaire in Hepatitis C (ADHEPTA)

HIV Infection | Hepatitis C, Chronic

Spain
Corporacion Parc Tauli

Completed

Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.

Liver Disease Chronic | Hepatitis B Virus

Spain
Hospitales Universitarios Virgen del Rocío
Bristol-Myers Squibb

Completed

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

HIV Infection | Hepatitis C, Chronic

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Hospital Universitari Vall d'Hebron Research Institute

Terminated

Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.

Hepatitis E

Spain
Jordi Gol i Gurina Foundation

Completed

Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum (EKOH-MOL 2008)

Molluscum Contagiosum

Spain
Hospital Clinic of Barcelona
University of Padova; Hospital Vall d'Hebron

Unknown

HBV Vaccine in Anti-core Positive Donors After LT

Hepatitis B Reactivation

Spain
Fundacion para la Investigacion Biomedica del Hospital...
Fundación Mutua Madrileña

Completed

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Hepatocellular Carcinoma | Acquired Immunodeficiency Syndrome Virus | Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Spain
Valme University Hospital
Hospital Universitario de Canarias; Hospital Universitario Virgen Macarena; Hospital... and other collaborators

Unknown

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Hepatitis C, Chronic | Human Immunodeficiency Virus

Spain
Fundación Pública Andaluza Progreso y Salud
Gilead Sciences

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." (hEPAtic)

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Spain
Valme University Hospital
University of Seville

Unknown

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance (TRITAL)

Hepatitis C

Spain
Corporacion Parc Tauli
Germans Trias i Pujol Hospital; Hospital Universitario La Fe; Hospital Mutua... and other collaborators

Recruiting

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Hepatitis B

Spain
Fundacion para la Investigacion Biomedica del Hospital...
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis (LIVERAL)

Hepatitis C | Human Immunodeficiency Virus

Spain
Barcelona Institute for Global Health
Hospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaborators

Completed

Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic (PrEP_COVID)

COVID-19

Spain
Increase-Tech
University of Valladolid; Hospital Clínico Universitario de Valladolid; Sanidad...

Completed

Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients (SOY+)

COVID-19

Spain
Universidad de Granada
Lithuanian University of Health Sciences; Bezmialem Vakif University; University... and other collaborators

Completed

Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) (COVIDiet_Int)

COVID-19

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4 (OPTIM)

Hepatitis C, Chronic

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Liver Cirrhosis | HIV Infection | Hepatitis C Virus

Spain
Dentaid SL
Methodex

Recruiting

Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)

Viral Pharyngitis

Spain
Institute of Agrochemistry and Food Technology,...
Universitat Jaume I; INCLIVA; Universidad de Granada; Hospital Universitario La Fe and other collaborators

Completed

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health (MilkCorona)

Covid19

Spain
Entera Health, Inc
Lemus Buhils, SL; Clinical Research Unit, IMIM (Hospital del Mar Medical Research...

Completed

Evaluating the Impact of EnteraGam In People With COVID-19 (PICNIC)

Covid19

Spain
Hospital San Carlos, Madrid

Completed

Transcranial Direct Stimulation for Persistent Fatigue Treatment Post-COVID-19 (STIMULATECOVID)

COVID-19

Spain
St Carlos Hospital, Madrid, Spain

Completed

International COVID-19 Clinical Evaluation Registry -2 (HOPE-2) (HOPE-2)

Covid19

Spain
University of Barcelona
Consorci Sanitari de Terrassa; Universitat Politècnica de Catalunya

Completed

COVID-19 and Brain: Cognition and Mental Health (DIANA)

COVID-19

Spain
Hospital Universitario Getafe

Unknown

Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial (GETAFE)

COVID-19

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Germans Trias i Pujol Hospital; Institut Catala de Salut; Department of Health... and other collaborators

Completed

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19)

COVID-19

Spain

Clinical Trials on Meningitis, Viral in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations